Mental Disorders

Omega-3 Supplements Linked to Faster Cognitive Decline in Older Adults

A longitudinal study using data from the Alzheimer’s Disease Neuroimaging Initiative found that omega-3 fatty acid supplementation was associated with accelerated cognitive decline in older adults, challenging the common belief that omega-3 universally protects brain health. Participants taking omega-3 supplements showed faster worsening in MMSE, ADAS-Cog13, and CDR-SB scores over time. Interestingly, the association was not explained by classical Alzheimer’s disease pathologies such as amyloid-β accumulation, tau deposition, or gray matter atrophy. Instead, reduced cerebral glucose metabolism on FDG-PET scans—reflecting impaired synaptic and neuronal function in AD-vulnerable brain regions—partially mediated the relationship, accounting for 19% to 41% of the observed cognitive decline. These findings suggest that omega-3 supplementation may adversely affect cerebral synaptic function in some older adults and highlight the need for a more cautious reassessment of its widespread use for cognitive protection. Source: https://www.sciencedirect.com/

hyangiu

Recent Posts

Function-Guided Complete Revascularization Improves Outcomes in STEMI

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease, complete coronary…

3 hours ago

2026 Fifth Universal Definition of Myocardial Infarction

The Fifth Universal Definition of Myocardial Infarction (MI) updates the classification of MI by defining…

3 hours ago

Updated US Guideline on Pharmacologic Prevention of Migraine in Adults

The US updated evidence-based recommendations provide clinicians with comprehensive guidance on when to initiate pharmacologic…

8 hours ago

Catheter-Directed Thrombolysis Improves Outcomes in Intermediate-High–Risk Pulmonary Embolism

In patients with intermediate-high–risk acute pulmonary embolism, catheter-directed thrombolysis with alteplase plus anticoagulation significantly reduced…

1 day ago

Atorvastatin Prevents Cardiovascular Events in Older Adults without Prior Cardiovascular Disease

In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by…

3 days ago

Aficamten Improves Exercise Capacity and Health Status in Nonobstructive HCM

In patients with symptomatic nonobstructive hypertrophic cardiomyopathy (HCM), aficamten significantly improved exercise capacity and patient-reported…

4 days ago

This website uses cookies.